BMRB Entry 17614
Click here to enlarge.
PDB ID:
Entry in NMR Restraints Grid
Validation report in NRG-CING
Chem Shift validation: AVS_full, LACS, SPARTA
BMRB Entry DOI: doi:10.13018/BMR17614
MolProbity Validation Chart
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
NMR-STAR v2.1 text file (deprecated)
XML gzip file.
RDF gzip file.
All files associated with the entry
Title: Structure of the mitochondrial uncoupling protein 2 determined by NMR molecular fragment replacement PubMed: 21785437
Deposition date: 2011-04-29 Original release date: 2011-08-02
Authors: Berardi, Marcelo; Chou, James
Citation: Berardi, Marcelo; Shih, William; Harrison, Stephen; Chou, James. "Mitochondrial uncoupling protein 2 structure determined by NMR molecular fragment searching." Nature 476, 109-113 (2011).
Assembly members:
UCP2, polymer, 303 residues, 32227.426 Da.
UCP2-SL1, polymer, 303 residues, 32227.426 Da.
UCP2-SL2, polymer, 303 residues, 32227.426 Da.
UCP2-SL3, polymer, 303 residues, 32227.426 Da.
UCP2-SL4, polymer, 303 residues, 32227.426 Da.
Natural source: Common Name: Mouse Taxonomy ID: 10090 Superkingdom: Eukaryota Kingdom: Metazoa Genus/species: Mus musculus
Experimental source: Production method: recombinant technology Host organism: Escherichia coli
Entity Sequences (FASTA):
UCP2: MTVKFLGAGTAACIADLITF
PLDTAKVRLQIQGESQGLVR
TAASAQYRGVLGTILTMVRT
EGPRSLYNGLVAGLQRQMSF
ASVRIGLYDSVKQFYTKGSE
HAGIGSRLLAGSTTGALAVA
VAQPTDVVKVRFQAQARAGG
GRRYQSTVEAYKTIAREEGI
RGLWKGTSPNVARNAIVNCA
ELVTYDLIKDTLLKANLMTD
DLPCHFTSAFGAGFCTTVIA
SPVDVVKTRYMNSALGQYHS
AGHCALTMLRKEGPRAFYKG
FMPSFLRLGSWNVVMFVTYE
QLKRALMAAYQSREAPFHHH
HHH
UCP2-SL1: MTVKFLGAGTAAAIADLITF
PLDTAKVRLQIQGESQGLVR
TAASAQYRGVLGTILCMVRT
EGPRSLYNGLVAGLQRQMSF
ASVRIGLYDSVKQFYTKGSE
HAGIGSRLLAGSTTGALAVA
VAQPTDVVKVRFQAQARAGG
GRRYQSTVEAYKTIAREEGI
RGLWKGTSPNVARNAIVNSA
ELVTYDLIKDTLLKANLMTD
DLPSHFTSAFGAGFSTTVIA
SPVDVVKTRYMNSALGQYHS
AGHSALTMLRKEGPRAFYKG
FMPSFLRLGSWNVVMFVTYE
QLKRALMAAYQSREAPFHHH
HHH
UCP2-SL2: MTVKFLGAGTAAAIADLITF
PLDTAKVRLQIQGESQGLVR
TAASAQYRGVLGTILTMVRT
EGPRSLYNGLVAGLQRQMSF
ASVRIGLYDSVKCFYTKGSE
HAGIGSRLLAGSTTGALAVA
VAQPTDVVKVRFQAQARAGG
GRRYQSTVEAYKTIAREEGI
RGLWKGTSPNVARNAIVNSA
ELVTYDLIKDTLLKANLMTD
DLPSHFTSAFGAGFSTTVIA
SPVDVVKTRYMNSALGQYHS
AGHSALTMLRKEGPRAFYKG
FMPSFLRLGSWNVVMFVTYE
QLKRALMAAYQSREAPFHHH
HHH
UCP2-SL3: MTVKFLGAGTAAAIADLITF
PLDTAKVRLQIQGESQGLVR
TAASAQYRGVLGTILTMVRT
EGPRSLYNGLVAGLQRQMSF
ASVRIGLYDSVKQFYTKGSE
HAGIGSRLLAGSTTGALAVA
VAQPTDVVKVRFQAQARAGG
GRRYQSTVEAYKTIAREEGI
RGLWKGTSPNVARNAIVNSA
ELVTYDLIKCTLLKANLMTD
DLPSHFTSAFGAGFSTTVIA
SPVDVVKTRYMNSALGQYHS
AGHSALTMLRKEGPRAFYKG
FMPSFLRLGSWNVVMFVTYE
QLKRALMAAYQSREAPFHHH
HHH
UCP2-SL4: MTVKFLGAGTAAAIADLITF
PLDTAKVRLQIQGESQGLVR
TAASAQYRGVLGTILTMVRT
EGPRSLYNGLVAGLQRQMSF
ASVRIGLYDSVKQFYTKGSE
HAGIGSRLLAGSTTGALAVA
VAQPTDVVKVRFQAQARAGG
GRRYQSTVEAYKTIAREEGI
RGLWKGTSPNVARNAIVNSA
ELVTYDLIKDTLLKANLMTD
DLPSHFTSAFGAGFSTTVIA
SPVDVVKTRYMNSALGQYHS
AGCSALTMLRKEGPRAFYKG
FMPSFLRLGSWNVVMFVTYE
QLKRALMAAYQSREAPFHHH
HHH
- assigned_chemical_shifts
Data type | Count |
13C chemical shifts | 695 |
15N chemical shifts | 236 |
1H chemical shifts | 249 |
Additional metadata:
Assembly:
Entity Assembly ID | Entity Name | Entity ID |
---|---|---|
1 | UCP2 | 1 |
2 | UCP2-SL1 | 2 |
3 | UCP2-SL2 | 3 |
4 | UCP2-SL3 | 4 |
5 | UCP2-SL4 | 5 |
Entities:
Entity 1, UCP2 303 residues - 32227.426 Da.
Residues 1-12 of the native sequence have been removed for structure determination
1 | MET | THR | VAL | LYS | PHE | LEU | GLY | ALA | GLY | THR | ||||
2 | ALA | ALA | CYS | ILE | ALA | ASP | LEU | ILE | THR | PHE | ||||
3 | PRO | LEU | ASP | THR | ALA | LYS | VAL | ARG | LEU | GLN | ||||
4 | ILE | GLN | GLY | GLU | SER | GLN | GLY | LEU | VAL | ARG | ||||
5 | THR | ALA | ALA | SER | ALA | GLN | TYR | ARG | GLY | VAL | ||||
6 | LEU | GLY | THR | ILE | LEU | THR | MET | VAL | ARG | THR | ||||
7 | GLU | GLY | PRO | ARG | SER | LEU | TYR | ASN | GLY | LEU | ||||
8 | VAL | ALA | GLY | LEU | GLN | ARG | GLN | MET | SER | PHE | ||||
9 | ALA | SER | VAL | ARG | ILE | GLY | LEU | TYR | ASP | SER | ||||
10 | VAL | LYS | GLN | PHE | TYR | THR | LYS | GLY | SER | GLU | ||||
11 | HIS | ALA | GLY | ILE | GLY | SER | ARG | LEU | LEU | ALA | ||||
12 | GLY | SER | THR | THR | GLY | ALA | LEU | ALA | VAL | ALA | ||||
13 | VAL | ALA | GLN | PRO | THR | ASP | VAL | VAL | LYS | VAL | ||||
14 | ARG | PHE | GLN | ALA | GLN | ALA | ARG | ALA | GLY | GLY | ||||
15 | GLY | ARG | ARG | TYR | GLN | SER | THR | VAL | GLU | ALA | ||||
16 | TYR | LYS | THR | ILE | ALA | ARG | GLU | GLU | GLY | ILE | ||||
17 | ARG | GLY | LEU | TRP | LYS | GLY | THR | SER | PRO | ASN | ||||
18 | VAL | ALA | ARG | ASN | ALA | ILE | VAL | ASN | CYS | ALA | ||||
19 | GLU | LEU | VAL | THR | TYR | ASP | LEU | ILE | LYS | ASP | ||||
20 | THR | LEU | LEU | LYS | ALA | ASN | LEU | MET | THR | ASP | ||||
21 | ASP | LEU | PRO | CYS | HIS | PHE | THR | SER | ALA | PHE | ||||
22 | GLY | ALA | GLY | PHE | CYS | THR | THR | VAL | ILE | ALA | ||||
23 | SER | PRO | VAL | ASP | VAL | VAL | LYS | THR | ARG | TYR | ||||
24 | MET | ASN | SER | ALA | LEU | GLY | GLN | TYR | HIS | SER | ||||
25 | ALA | GLY | HIS | CYS | ALA | LEU | THR | MET | LEU | ARG | ||||
26 | LYS | GLU | GLY | PRO | ARG | ALA | PHE | TYR | LYS | GLY | ||||
27 | PHE | MET | PRO | SER | PHE | LEU | ARG | LEU | GLY | SER | ||||
28 | TRP | ASN | VAL | VAL | MET | PHE | VAL | THR | TYR | GLU | ||||
29 | GLN | LEU | LYS | ARG | ALA | LEU | MET | ALA | ALA | TYR | ||||
30 | GLN | SER | ARG | GLU | ALA | PRO | PHE | HIS | HIS | HIS | ||||
31 | HIS | HIS | HIS |
Entity 2, UCP2-SL1 303 residues - 32227.426 Da.
All native Cys have been mutated with C25A, C191S, C217S, C227S, C256S mutations. A single Cys (T68C) was introduced for MTSL labeling.
1 | MET | THR | VAL | LYS | PHE | LEU | GLY | ALA | GLY | THR | ||||
2 | ALA | ALA | ALA | ILE | ALA | ASP | LEU | ILE | THR | PHE | ||||
3 | PRO | LEU | ASP | THR | ALA | LYS | VAL | ARG | LEU | GLN | ||||
4 | ILE | GLN | GLY | GLU | SER | GLN | GLY | LEU | VAL | ARG | ||||
5 | THR | ALA | ALA | SER | ALA | GLN | TYR | ARG | GLY | VAL | ||||
6 | LEU | GLY | THR | ILE | LEU | CYS | MET | VAL | ARG | THR | ||||
7 | GLU | GLY | PRO | ARG | SER | LEU | TYR | ASN | GLY | LEU | ||||
8 | VAL | ALA | GLY | LEU | GLN | ARG | GLN | MET | SER | PHE | ||||
9 | ALA | SER | VAL | ARG | ILE | GLY | LEU | TYR | ASP | SER | ||||
10 | VAL | LYS | GLN | PHE | TYR | THR | LYS | GLY | SER | GLU | ||||
11 | HIS | ALA | GLY | ILE | GLY | SER | ARG | LEU | LEU | ALA | ||||
12 | GLY | SER | THR | THR | GLY | ALA | LEU | ALA | VAL | ALA | ||||
13 | VAL | ALA | GLN | PRO | THR | ASP | VAL | VAL | LYS | VAL | ||||
14 | ARG | PHE | GLN | ALA | GLN | ALA | ARG | ALA | GLY | GLY | ||||
15 | GLY | ARG | ARG | TYR | GLN | SER | THR | VAL | GLU | ALA | ||||
16 | TYR | LYS | THR | ILE | ALA | ARG | GLU | GLU | GLY | ILE | ||||
17 | ARG | GLY | LEU | TRP | LYS | GLY | THR | SER | PRO | ASN | ||||
18 | VAL | ALA | ARG | ASN | ALA | ILE | VAL | ASN | SER | ALA | ||||
19 | GLU | LEU | VAL | THR | TYR | ASP | LEU | ILE | LYS | ASP | ||||
20 | THR | LEU | LEU | LYS | ALA | ASN | LEU | MET | THR | ASP | ||||
21 | ASP | LEU | PRO | SER | HIS | PHE | THR | SER | ALA | PHE | ||||
22 | GLY | ALA | GLY | PHE | SER | THR | THR | VAL | ILE | ALA | ||||
23 | SER | PRO | VAL | ASP | VAL | VAL | LYS | THR | ARG | TYR | ||||
24 | MET | ASN | SER | ALA | LEU | GLY | GLN | TYR | HIS | SER | ||||
25 | ALA | GLY | HIS | SER | ALA | LEU | THR | MET | LEU | ARG | ||||
26 | LYS | GLU | GLY | PRO | ARG | ALA | PHE | TYR | LYS | GLY | ||||
27 | PHE | MET | PRO | SER | PHE | LEU | ARG | LEU | GLY | SER | ||||
28 | TRP | ASN | VAL | VAL | MET | PHE | VAL | THR | TYR | GLU | ||||
29 | GLN | LEU | LYS | ARG | ALA | LEU | MET | ALA | ALA | TYR | ||||
30 | GLN | SER | ARG | GLU | ALA | PRO | PHE | HIS | HIS | HIS | ||||
31 | HIS | HIS | HIS |
Entity 3, UCP2-SL2 303 residues - 32227.426 Da.
All native Cys have been mutated with C25A, C191S, C217S, C227S, C256S mutations. A single Cys (Q105C) was introduced for MTSL labeling.
1 | MET | THR | VAL | LYS | PHE | LEU | GLY | ALA | GLY | THR | ||||
2 | ALA | ALA | ALA | ILE | ALA | ASP | LEU | ILE | THR | PHE | ||||
3 | PRO | LEU | ASP | THR | ALA | LYS | VAL | ARG | LEU | GLN | ||||
4 | ILE | GLN | GLY | GLU | SER | GLN | GLY | LEU | VAL | ARG | ||||
5 | THR | ALA | ALA | SER | ALA | GLN | TYR | ARG | GLY | VAL | ||||
6 | LEU | GLY | THR | ILE | LEU | THR | MET | VAL | ARG | THR | ||||
7 | GLU | GLY | PRO | ARG | SER | LEU | TYR | ASN | GLY | LEU | ||||
8 | VAL | ALA | GLY | LEU | GLN | ARG | GLN | MET | SER | PHE | ||||
9 | ALA | SER | VAL | ARG | ILE | GLY | LEU | TYR | ASP | SER | ||||
10 | VAL | LYS | CYS | PHE | TYR | THR | LYS | GLY | SER | GLU | ||||
11 | HIS | ALA | GLY | ILE | GLY | SER | ARG | LEU | LEU | ALA | ||||
12 | GLY | SER | THR | THR | GLY | ALA | LEU | ALA | VAL | ALA | ||||
13 | VAL | ALA | GLN | PRO | THR | ASP | VAL | VAL | LYS | VAL | ||||
14 | ARG | PHE | GLN | ALA | GLN | ALA | ARG | ALA | GLY | GLY | ||||
15 | GLY | ARG | ARG | TYR | GLN | SER | THR | VAL | GLU | ALA | ||||
16 | TYR | LYS | THR | ILE | ALA | ARG | GLU | GLU | GLY | ILE | ||||
17 | ARG | GLY | LEU | TRP | LYS | GLY | THR | SER | PRO | ASN | ||||
18 | VAL | ALA | ARG | ASN | ALA | ILE | VAL | ASN | SER | ALA | ||||
19 | GLU | LEU | VAL | THR | TYR | ASP | LEU | ILE | LYS | ASP | ||||
20 | THR | LEU | LEU | LYS | ALA | ASN | LEU | MET | THR | ASP | ||||
21 | ASP | LEU | PRO | SER | HIS | PHE | THR | SER | ALA | PHE | ||||
22 | GLY | ALA | GLY | PHE | SER | THR | THR | VAL | ILE | ALA | ||||
23 | SER | PRO | VAL | ASP | VAL | VAL | LYS | THR | ARG | TYR | ||||
24 | MET | ASN | SER | ALA | LEU | GLY | GLN | TYR | HIS | SER | ||||
25 | ALA | GLY | HIS | SER | ALA | LEU | THR | MET | LEU | ARG | ||||
26 | LYS | GLU | GLY | PRO | ARG | ALA | PHE | TYR | LYS | GLY | ||||
27 | PHE | MET | PRO | SER | PHE | LEU | ARG | LEU | GLY | SER | ||||
28 | TRP | ASN | VAL | VAL | MET | PHE | VAL | THR | TYR | GLU | ||||
29 | GLN | LEU | LYS | ARG | ALA | LEU | MET | ALA | ALA | TYR | ||||
30 | GLN | SER | ARG | GLU | ALA | PRO | PHE | HIS | HIS | HIS | ||||
31 | HIS | HIS | HIS |
Entity 4, UCP2-SL3 303 residues - 32227.426 Da.
All native Cys have been mutated with C25A, C191S, C217S, C227S, C256S mutations. A single Cys (D202C) was introduced for MTSL labeling.
1 | MET | THR | VAL | LYS | PHE | LEU | GLY | ALA | GLY | THR | ||||
2 | ALA | ALA | ALA | ILE | ALA | ASP | LEU | ILE | THR | PHE | ||||
3 | PRO | LEU | ASP | THR | ALA | LYS | VAL | ARG | LEU | GLN | ||||
4 | ILE | GLN | GLY | GLU | SER | GLN | GLY | LEU | VAL | ARG | ||||
5 | THR | ALA | ALA | SER | ALA | GLN | TYR | ARG | GLY | VAL | ||||
6 | LEU | GLY | THR | ILE | LEU | THR | MET | VAL | ARG | THR | ||||
7 | GLU | GLY | PRO | ARG | SER | LEU | TYR | ASN | GLY | LEU | ||||
8 | VAL | ALA | GLY | LEU | GLN | ARG | GLN | MET | SER | PHE | ||||
9 | ALA | SER | VAL | ARG | ILE | GLY | LEU | TYR | ASP | SER | ||||
10 | VAL | LYS | GLN | PHE | TYR | THR | LYS | GLY | SER | GLU | ||||
11 | HIS | ALA | GLY | ILE | GLY | SER | ARG | LEU | LEU | ALA | ||||
12 | GLY | SER | THR | THR | GLY | ALA | LEU | ALA | VAL | ALA | ||||
13 | VAL | ALA | GLN | PRO | THR | ASP | VAL | VAL | LYS | VAL | ||||
14 | ARG | PHE | GLN | ALA | GLN | ALA | ARG | ALA | GLY | GLY | ||||
15 | GLY | ARG | ARG | TYR | GLN | SER | THR | VAL | GLU | ALA | ||||
16 | TYR | LYS | THR | ILE | ALA | ARG | GLU | GLU | GLY | ILE | ||||
17 | ARG | GLY | LEU | TRP | LYS | GLY | THR | SER | PRO | ASN | ||||
18 | VAL | ALA | ARG | ASN | ALA | ILE | VAL | ASN | SER | ALA | ||||
19 | GLU | LEU | VAL | THR | TYR | ASP | LEU | ILE | LYS | CYS | ||||
20 | THR | LEU | LEU | LYS | ALA | ASN | LEU | MET | THR | ASP | ||||
21 | ASP | LEU | PRO | SER | HIS | PHE | THR | SER | ALA | PHE | ||||
22 | GLY | ALA | GLY | PHE | SER | THR | THR | VAL | ILE | ALA | ||||
23 | SER | PRO | VAL | ASP | VAL | VAL | LYS | THR | ARG | TYR | ||||
24 | MET | ASN | SER | ALA | LEU | GLY | GLN | TYR | HIS | SER | ||||
25 | ALA | GLY | HIS | SER | ALA | LEU | THR | MET | LEU | ARG | ||||
26 | LYS | GLU | GLY | PRO | ARG | ALA | PHE | TYR | LYS | GLY | ||||
27 | PHE | MET | PRO | SER | PHE | LEU | ARG | LEU | GLY | SER | ||||
28 | TRP | ASN | VAL | VAL | MET | PHE | VAL | THR | TYR | GLU | ||||
29 | GLN | LEU | LYS | ARG | ALA | LEU | MET | ALA | ALA | TYR | ||||
30 | GLN | SER | ARG | GLU | ALA | PRO | PHE | HIS | HIS | HIS | ||||
31 | HIS | HIS | HIS |
Entity 5, UCP2-SL4 303 residues - 32227.426 Da.
All native Cys have been mutated with C25A, C191S, C217S, C227S, C256S mutations. A single Cys (H255C) was introduced for MTSL labeling.
1 | MET | THR | VAL | LYS | PHE | LEU | GLY | ALA | GLY | THR | ||||
2 | ALA | ALA | ALA | ILE | ALA | ASP | LEU | ILE | THR | PHE | ||||
3 | PRO | LEU | ASP | THR | ALA | LYS | VAL | ARG | LEU | GLN | ||||
4 | ILE | GLN | GLY | GLU | SER | GLN | GLY | LEU | VAL | ARG | ||||
5 | THR | ALA | ALA | SER | ALA | GLN | TYR | ARG | GLY | VAL | ||||
6 | LEU | GLY | THR | ILE | LEU | THR | MET | VAL | ARG | THR | ||||
7 | GLU | GLY | PRO | ARG | SER | LEU | TYR | ASN | GLY | LEU | ||||
8 | VAL | ALA | GLY | LEU | GLN | ARG | GLN | MET | SER | PHE | ||||
9 | ALA | SER | VAL | ARG | ILE | GLY | LEU | TYR | ASP | SER | ||||
10 | VAL | LYS | GLN | PHE | TYR | THR | LYS | GLY | SER | GLU | ||||
11 | HIS | ALA | GLY | ILE | GLY | SER | ARG | LEU | LEU | ALA | ||||
12 | GLY | SER | THR | THR | GLY | ALA | LEU | ALA | VAL | ALA | ||||
13 | VAL | ALA | GLN | PRO | THR | ASP | VAL | VAL | LYS | VAL | ||||
14 | ARG | PHE | GLN | ALA | GLN | ALA | ARG | ALA | GLY | GLY | ||||
15 | GLY | ARG | ARG | TYR | GLN | SER | THR | VAL | GLU | ALA | ||||
16 | TYR | LYS | THR | ILE | ALA | ARG | GLU | GLU | GLY | ILE | ||||
17 | ARG | GLY | LEU | TRP | LYS | GLY | THR | SER | PRO | ASN | ||||
18 | VAL | ALA | ARG | ASN | ALA | ILE | VAL | ASN | SER | ALA | ||||
19 | GLU | LEU | VAL | THR | TYR | ASP | LEU | ILE | LYS | ASP | ||||
20 | THR | LEU | LEU | LYS | ALA | ASN | LEU | MET | THR | ASP | ||||
21 | ASP | LEU | PRO | SER | HIS | PHE | THR | SER | ALA | PHE | ||||
22 | GLY | ALA | GLY | PHE | SER | THR | THR | VAL | ILE | ALA | ||||
23 | SER | PRO | VAL | ASP | VAL | VAL | LYS | THR | ARG | TYR | ||||
24 | MET | ASN | SER | ALA | LEU | GLY | GLN | TYR | HIS | SER | ||||
25 | ALA | GLY | CYS | SER | ALA | LEU | THR | MET | LEU | ARG | ||||
26 | LYS | GLU | GLY | PRO | ARG | ALA | PHE | TYR | LYS | GLY | ||||
27 | PHE | MET | PRO | SER | PHE | LEU | ARG | LEU | GLY | SER | ||||
28 | TRP | ASN | VAL | VAL | MET | PHE | VAL | THR | TYR | GLU | ||||
29 | GLN | LEU | LYS | ARG | ALA | LEU | MET | ALA | ALA | TYR | ||||
30 | GLN | SER | ARG | GLU | ALA | PRO | PHE | HIS | HIS | HIS | ||||
31 | HIS | HIS | HIS |
Samples:
sample_1: UCP2, [U-100% 13C; U-100% 15N; U-80% 2H], 0.8 mM; guanosine diphosphate 5 mM; dodecylphosphocholine 150 mM; cardiolipin 1 mM; dimyristoyl-phosphatidylcholine 2 mM; beta-mercatpoethanol 5 mM; potassium phosphate 30 mM; sodium chloride 80 mM; H2O 95%; D2O 5%
sample_2: UCP2, [U-100% 13C; U-100% 15N; U-80% 2H], 0.5 mM; guanosine diphosphate 5 mM; dodecylphosphocholine 150 mM; cardiolipin 1 mM; dimyristoyl-phosphatidylcholine 2 mM; beta-mercatpoethanol 5 mM; potassium phosphate 30 mM; sodium chloride 80 mM; DNA nanotube 2 ± 0.2 w/v; H2O 95%; D20 5%
sample_3: UCP2-SL1, [U-100% 13C; U-100% 15N; U-80% 2H], 0.8 mM; guanosine diphosphate 5 mM; dodecylphosphocholine 150 mM; cardiolipin 1 mM; dimyristoyl-phosphatidylcholine 2 mM; beta-mercatpoethanol 5 mM; potassium phosphate 30 mM; sodium chloride 80 mM; H2O 95%; D2O 5%
sample_4: UCP2-SL2, [U-100% 13C; U-100% 15N; U-80% 2H], 0.8 mM; guanosine diphosphate 5 mM; dodecylphosphocholine 150 mM; cardiolipin 1 mM; dimyristoyl-phosphatidylcholine 2 mM; beta-mercatpoethanol 5 mM; potassium phosphate 30 mM; sodium chloride 80 mM; H2O 95%; D2O 5%
sample_5: UCP2-SL3, [U-100% 13C; U-100% 15N; U-80% 2H], 0.8 mM; guanosine diphosphate 5 mM; dodecylphosphocholine 150 mM; cardiolipin 1 mM; dimyristoyl-phosphatidylcholine 2 mM; beta-mercatpoethanol 5 mM; potassium phosphate 30 mM; sodium chloride 80 mM; H2O 95%; D2O 5%
sample_6: UCP2-SL4, [U-100% 13C; U-100% 15N; U-80% 2H], 0.8 mM; guanosine diphosphate 5 mM; dodecylphosphocholine 150 mM; cardiolipin 1 mM; dimyristoyl-phosphatidylcholine 2 mM; beta-mercatpoethanol 5 mM; potassium phosphate 30 mM; sodium chloride 80 mM; H2O 95%; D2O 5%
sample_conditions_1: ionic strength: 150 mM; pH: 6.5; pressure: 1 atm; temperature: 306 K
Experiments:
Name | Sample | Sample state | Sample conditions |
---|---|---|---|
2D 1H-15N TROSY-HSQC | sample_1 | isotropic | sample_conditions_1 |
3D TROSY-HNCA | sample_1 | isotropic | sample_conditions_1 |
3D TROSY-HN(CO)CA | sample_1 | isotropic | sample_conditions_1 |
3D TROSY-HNCACB | sample_1 | isotropic | sample_conditions_1 |
3D TROSY-HN(CO)CACB | sample_1 | isotropic | sample_conditions_1 |
3D TROSY-HN(CA)CO | sample_1 | isotropic | sample_conditions_1 |
3D TROSY-HNCO | sample_1 | isotropic | sample_conditions_1 |
3D (HN,HN)-HMQC-NOESY-TROSY | sample_1 | isotropic | sample_conditions_1 |
3D J(NH)-scaled TROSY-HNCO | sample_1 | isotropic | sample_conditions_1 |
3D J(NH)-scaled TROSY-HNCO | sample_2 | anisotropic | sample_conditions_1 |
3D quantitative J(C | not available | 1 | not available |
1 | not available | not available | nisotropic |
not available | not available | not available | not available |
not available | not available | not available | not available |
not available | not available | not available | not available |
not available | not available | not available | not available |
not available | not available | not available | not available |
not available | not available | not available | not available |
not available | not available | not available | not available |
Software:
NMRPipe v3.0, Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax - processing
NMRDraw v3.0, Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax - data analysis
XEASY, Bartels et al. - chemical shift assignment
X-PLOR NIH v2.26, Schwieters, Kuszewski, Tjandra and Clore - refinement, structure solution
NMR spectrometers:
- Bruker Avance 600 MHz
Related Database Links:
PDB | |
DBJ | BAA23383 BAA25698 BAA28832 BAA32532 BAC29021 BAA23383 BAA28832 BAA32532 BAC29021 BAC35641 BAA23383 BAA28832 BAA32532 BAC29021 BAC35641 BAA23383 BAA28832 BAA32532 BAC29021 BAC35641 BAA23383 BAA28832 BAA32532 BAC29021 BAC35641 |
GB | AAB17666 AAB53092 AAC98733 AAD17198 AAD17199 AAB17666 AAB53092 AAC98733 AAD17198 AAD17199 AAB17666 AAB53092 AAC98733 AAD17198 AAD17199 AAB17666 AAB53092 AAC98733 AAD17198 AAD17199 AAB17666 AAB53092 AAC98733 AAD17198 AAD17199 |
REF | NP_035801 NP_062227 XP_003511817 XP_005357555 XP_006507642 NP_035801 NP_062227 XP_006507642 XP_006982207 NP_035801 NP_062227 XP_006507642 XP_006982207 NP_035801 NP_062227 XP_006507642 XP_006982207 NP_035801 NP_062227 XP_006507642 XP_006982207 |
SP | P56500 P70406 P56500 P70406 P56500 P70406 P56500 P70406 P56500 P70406 |
Download simulated HSQC data in one of the following formats:
CSV: Backbone
or all simulated shifts
SPARKY: Backbone
or all simulated shifts